Adson Santos Neves

Adson Santos Neves

Auto-generated profile, based on publicly available information

Adson Santos Neves

Faculty of Medicine, Universidade Federal da Bahia, Salvador, Bahia, Brazil

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2025 in Anais Brasileiros de Dermatologia (Versão em Português)
Verified
Journal Article
Open access
TFThiago Francischetto
Thiago Francischetto
AFAna Clara Falcão
Ana Clara Falcão
ANAdson Santos Neves
Adson Santos Neves
ALAna Beatriz Lira
Ana Beatriz Lira
RMRobson Freitas de Moura
Robson Freitas de Moura
VPVaner Paulo da Silva Fonseca Pinheiro
Vaner Paulo da Silva Fonseca Pinheiro

18 June 2025 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
TFThiago Francischetto
Thiago Francischetto
AFAna Clara Falcão
Ana Clara Falcão
ANAdson Santos Neves
Adson Santos Neves
ALAna Beatriz Lira
Ana Beatriz Lira
RMRobson Freitas de Moura
Robson Freitas de Moura
VPVaner Paulo da Silva Fonseca Pinheiro
Vaner Paulo da Silva Fonseca Pinheiro
Sentinel lymph node (SLN) biopsy in melanoma patients has an important role in staging, prognosis assessment, and treatment definition. Few studies have evaluated its role in the Acral Melanoma (AM) subtype. To evaluate the results of SLN biopsy in 79 patients with acral melanoma treated at a single oncological center and compare them with the data described in the literature. Between January 2016 and December 2022, the authors analyzed all patients with AM who underwent SLN biopsy in a single institute. The authors analyzed the epidemiological, clinical and histopathological data. Overall Survival (OS) and Disease-Free Survival (DFS) curves were estimated using the Kaplan-Meier method. Multivariate analyses were conducted using the Cox regression model. During the period, the authors analyzed 79 cases. The mean age was 60 years and median thickness was 4.5 mm and 67.1% had ulceration. SLN was positive in 27 patients (34.2%). The estimated OS and DFS were 67.7% and 45.2%. OS was better in the negative SLN group compared to the positive SLN group (70.9% vs. 53.2%), but without statistical significance (p = 0.08). Estimated DFS for positive SLN was associated with a significantly worse prognosis (33.8 × 46.7%, p = 0.001). The retrospective nature of the study and the limited number of patients. The present study has significant implications for determining prognosis. Patients with AM and positive SLN had a worst prognosis compared to those with negative SLN.